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Litl,mea wI/stim, or litre, a tree of the Anacardiaceae 
family that is endemic to the central region of Chile, 
induces a severe contact dermatitis in susceptible 
human beings. The allergen was previously isolated 
and characterized as a 3-(pentadecyl- l0- enyl) cate-
chol, a molecule belonging to the urushiol group of 
allergens isolated froln poison ivy and poison oak 
plants . Because urushiols are pro-electrophilic hap-
tens, it is believed that the reactive species are gen-
erated intracellularly by skin keratinocytes and Lang-
erhans cells . The active species are presumed to 
modify self proteins which, after proteolytic process-
ing, would generate immunogenic peptides carrying 
the hapten . The presence of a 15 - carbon-Iength hy-
drophobic chain should impair antigen presentation 
of sel f-modified peptides by class I MHC molecules, 
either by steric hindrance or by limiting their sorting 
to the ER lumen. We have proposed that the short-
A ll ergic contact de rm atitis induced by contac t sens i-ti zers o r haptens has been hi sto ri ca ll y class ifie d as a de layed h ypersensiti vity- type respo nse on the ba sis o f the tim e cou rse of the reactio n (Ben ezra and Dupuis, 1983) and the in volve ment o f cell-m edi a ted 
immunity (Meltzer l'1 nl , 1989 ; Be nezra , 1990) . T he cogniti ve phase 
o f th ese reac tio n s is th o ugh t to be in itiated by th e co valent bo nd in g 
of th e hapte n v ia e lectro phili c att:lck o n amin o ac id res idu es o f 
se lf-pro te in s. T he m odified self-pro te ins . afte r anti geni c processin g 
by skin La !l ge rh ans ce lls, gene nlte !lo n- se lf- like immu nogeni c 
pep tides that tri gger th e speciti c respo llSe in the context of the 
m aj o r hi stocol11patibili ty complex (MH C) m o lecul es in the lymp h 
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ening of the aliphatic chain by ~-oxidation within 
peroxisomes and/or mitochondria should be a re-
quirelnent for the antigen presentation proce ss. To 
test this hypothesis we investigated the effect of drugs 
that modify the fatty acid metabolism on urushiol-
induced contact dermatitis in mice. Clofibrate, a 
peroxisolnal proliferator in Jnice, increased the itn-
mune response to the urushiols from litre b y 50%. 
Conversely, tetradecyl glycidic acid, an inhibitor o f 
the uptake of fatty acids by mitochondria, decreased 
the hypersensitivity to the hapten. An increase in the 
level in glutathione by treatnlent of the animals w ith 
2- oxotiazolidin- 4- carboxilic acid lowered the re-
sponse. Those findings strongly support a role for the 
fatty acid oxidative metabolism in the processing and 
activation of urushiols ;11 ";"0 . Key lIJol,ds: allel-gyl 
c/oji.lllratelderlllatitis/lUrelv/IIIs. ] I ,w est Denllato[ 108:57-
61, 1997 
nodes (llenezra and D u pui s, 1983). At t he effector ph ase of th e 
contac t de rma titis ke ra tin ocytes, in additi on to Lan gerh<l11s cell s, 
partic ipate by presentin g self-mo dified immunogeni c pcp tides to 
specific T lymphocytes (Ka lish, 199 1) . T he na tme of som e murine 
se lf- m o difi ed peptid es in volved in experimenta l contact derm atitis 
has been recentl y d escribed fo r e lectro phili c hapten s such as 
dini troAuo ro benz ene and trinitro -hl o roben zen e (Martin and W cl t-
z ien. 1994) . Fro m th ese stud ies it is c lea r that, fo r m ost o f the T - cell 
clo n es, the hapten is the iml11unodominan t group , w h ereas the 
ba ckbon e of the imt11nun ogenic pe ptide pani cipates in the bind ing 
to th e MH C t110 lecul e (Martin CI fl l , '1993 ; C avani el nl , 1995) . 
T he ro le of diffe rent po pula tion s of T cell s in com act dermatiti s 
has heen controversial. Earlie r studi es suppo rted the notion that 
C D 4 ' cell s w o uld be th e e ffec to rs in contac t de1'l11atitis as described 
fo r o the r de b yed type hypersensiti v ity reactio ns (Pta k 1'1 nl , 199 1; 
Wa ld o rf 1'1 fl i . 199 1), but ill II illa experiments usin g {3- 2 mi croglobu-
lin kn ockou t mi ce (Bo ur e/ nl , 1995) and immun o depleted mi ce 
(Gocin ski and Tigelaar, 1990) indi cate that CDS t- lymph ocytes arc 
the 1I1 ;uo r efFector ce ll s ill IIillO fo r the respo nse to dinitroAuo ro ben-
zene in th ose an im als. Furthermo l·e. C D S" cell s G ll1 diffe rentiate to 
e ffector cells in th e absen ce of C D 4 + . beca use kn ockout mi ce fo r 
cl ass II MH C and CD4 ' -depl e ted mice ca n develo p a str on ger 
specifi c contac t de rmati tis respom c th an no rm al mice (Gocin ski and 
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Tigclaa r, 1990; Bo ur cl (/1, 1995). In these experiments, CD4 + T 
cell s seem to playa dual ro le, act ing as suppressor and contrasup-
pressor in the system. Currently. the cellular basis of con tac t 
de rmatitis suggests that the endocytic path way of antigen process-
ing and presentation is the major determinant in tbe development 
of th is kind of h ypersensitiv ity (Ka lish e/ (/1, :J 994). 
Urushiols , th e contact se nsitizers secreted by plants belonging to 
the Anacardiaceae fam il y (Gillis, 1971; Dawson, 1973; Gal11bal·o cl 
(/1, 1986), arc respons ible for severe occupationa l dermatitis in 
densely populated areas (Johnson ct ai, 1972; Benezra, 1990). 
Urushio ls are a fam ily of lipophilic molecules consistin g of a 
catechol ring substituted w ith a CIS or C 17 hydrocarbon chain at 
position 4 (Johnson c/ aI, 1972; Gambaro cl (/1 , 1986). In con trast to 
e lectrophilic h aptellS, urushi o ls cannot modify self-proteins di-
rectly; t herefore, they mu st first be activated to an e lectrophilic 
rea ctive species by the h ost. T he most accepted model for activa-
tion of urush.io ls is the ir oxidation to a quinone intermediate 
(Schmid t c/ (/1, 1990). 111 1I;lro, these reactive species can attack 
nucleophili c groups of proteins. The role of ox idative en zym es in 
the activation of urushiols ;11 ,, ;110 is not clear. Also, it h as been 
proposed that thi s activation may involve the parti c ipati on of free 
rad ical in term ediates (Schmidt CI (/1, 1990). 
It has been reported th at, in human s, both the size of the chain 
and th e number of unsaturated bonds influence the immununoge-
nicier of th ese m o lecules. Aliphatic cha ins w ith 15 to 17 carbons are 
m ore immullogen ic than sh orter o n es (Ke il eI ai, 1944; Johllson el 
(/ 1, 1972). Moreover, the monoolefin and diolefin arc more al ler-
genic than the saturated chains. The findin gs indiolte that both the 
lack of saturation and the len gth of the a liph atic chain play an 
important ro le in the immunogen.ic ity of uru shi o ls. 
It is gen erally accepted that the aliphatic ch ;lin of urushio ls allows 
the hapten to bind and to be in serted on the cytopla smic membran e 
of epidermal cell s, which all ows the a ll e rgen to react w ith mem-
bran e proteins and/or to be internalized by skin cells fo r activatio n 
(Benezra. 1990; Ka li sh , 1991). Lit tl e attention has been paid, 
however , to the e ffect of the bulky a liph atic chain o n antigen 
processing and presentation of urushio l-m odi fi ed self-protei ns. We 
propose that th e activatio n of urushio ls by ;\l1tigen-prescnting cells 
involves the partia l or complete shortening of the hydrocarbon 
chain by m ea ns of the fatty acid oxidative metabo li sm. T his 
hypoth esis associates the cata bo lism of the aliph atic cha in w ith the 
activation of the catecholi c rin g to the rea ctive qui non e o r the 
radica l inte rmediate, e ith er in pe rox isoll1es or mitochondria. To test 
this m odel for the activatio n and processin g of urus/tiols, we 
investigated th e effect of drugs th at influence fatty acid metabolism 
on the onset of the contact se nsitivity induced by those allegens in 
mice. In accord with ou r hypothes is, c lofibrate, a pe rox isoma l alld 
P-450 indu cer , en hances the response to urushio l. COll ve rsely, 
tetradecyl-glycidi c ac id (TOGA), an inhi bitor of fatty ac id up take 
by mitochondria, decreases th e response, and 2-oxo-2-thi azo lidin e 
ca rboxyl ate (OTC), a stimula to r of the g lll that ione syn thes is, also 
decreases tlle intensity of th e infl all1m~tory reaction. 
MATEIUALS AND METHODS 
Experimental Animals Balb/c mice (Ponti fici :. Uni vers idad C atolica de 
C hile. Facul r:ld de C iencias Bio logicas and 13I0S0NDA S.A.) I to 2 111 0 o f 
age ;lItd l11aintaincd unde r approved in stitutiona l g uide lin es \Vere used. 
Allergens 3-Pcntadecyl C1 O-ellyl) catechol (PDC) was extracted with 
pctro )cu lll eth e r frolll air-d ri ed ste l11. b ark. and leaves of Lifllroca ((lIIs/iea 
from trees grown ill the O lmuc area (V region of C hile) in 1995. T he 
extract containing urushiols was purified by .<i lica ge l columll chrolll atog-
raphy as described elsewhere (Garnbaro ,"I nl, 1986). T he product was shown 
to be homogeneous by thill layer r hromat( gnlphy. Dinitrochro lobenze lle 
\va s of p h arnlaco logic gracle. 
Contact Sensitization Un less otherwise indicated. mice we re painted 
with 50 I.LI of a sol"tion cOllfailling the allergen in chl oroform. di.stribuwd 
0 11 11.75 cm' of shaved abdomen. We used stock so lu tions of 1'10, I'D and 
5'10, din itrochlorohellzelle (DNCU). 
Testing for Contact Sensitivity After measurel1lent of the baselille 
thi ckness of both ca rs, mice were chall enged with I () 1-'1 of either 0.5% PDC 
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or O.G'Yo, DNCB dissolved in chloroform app lied to both sides of OI.le car; the 
other car was used as contro l. bein~ tr"ated on ly with the solvent. This basic 
protocol W:IS used with min or modifications dependin~ upon specifiC 
ex periments. T he response to I'DC and DNCB was detennill cd by mea. 
suring the car th ickness using a engineering 11lic rOlTlctcr (111odcl 7326 
Mitutoyo , Oolla Easrc rn Co. 36-08 48th Avenue, Lon~ Island City, NY) 
eq uipped with a ga uge dial llIodel 2804. T I, e ear-swe ll ing respouse was 
calc ul ated by subtracting the car thickness prior to testin~ ii·om the thickness 
observed during the experiment. The control e:l1· was c hall e n~cd with 
chlorofornl a lo ne. The resu lts arc expressed as ll1can increases in car 
thickness :t SEM for each gro llp of mice over baseline va illes in microns. All 
experimenta l groups comprised five animals. 
Drugs Clofibrate, Azionyl (ethyl p-chloro phenoxy butiratc). was fronl 
Im pe rial Chemical Industries, Pharmace uticals (MacclesfIe ld , C heshire, 
England). TOGA from McNeil Pharmaceutical (Sprin~ House, PAl Was a 
generous gift from Dr. Federico Leighton (Facultad de Ciencias Biologicas, 
Pontiflcia Uni ve rsidad Catolica). OTC was purchased from Sigma C hem_ 
ica l Co. (St. LOllis, MO). 
Enzyme Assays T he activity of the peroxisomal cat'l lase was determined 
as described by Leighton ci nl (1968). Fatty ac id oxidase was measured as 
descri bed by lnestrosa el nl (1979). 
Pre-trcatlnent with Drugs 
e itUibrt/lc Animals were sensitized as described above . T he dru~ trt!atment 
was sta rted 8 dafter l'DC sensitization, consisting of six daily in traperitoneal 
injections of 20 m~ of cioflbr"tc in 200 /1-1 of oli v!! oil. Control animals 
received 200 /1-1 of oli ve oi l. In para lld , another ~roup of mi ce was s!! nsitized 
with ONCB, as described above, and submitted to the same pharmacologic 
treatment. Fourteen da),s after sensitization the mice were challenged with 
POC or DNCB. and the contact dermatitis response w;., measured as 
described above. 
TDGA Animals we re sensitized as described above. Drug treatment was 
.Hafted 8 dafter POC sensitization. consi.sting of fo ur doses oj" 400 , .... g of 
TDGA dissolved in 200 /1-1 of a solu tion of bovine serum albullIin-1 () mg 
10% II-butanol per 1111 in wate r. The injections were admini stered at 8-h 
interval s (24-h treatll1em) . Control anim als received 200 / .... 1 of a solu tion or 
bovin e seruln albumin ill 1 O')"u n-butanol ill wate r. In parallcl. another group 
of mice was sI!nsitized with ONCB. as described above, and submi tted to 
the same pharlllaco lo~ic trea tment. Six hours after the first elose of TI)GA, 
mice were challenged with POC or ONC[J. :md the contact dennatitis 
response was nt casurcd . 
OTe Animals were sensitized as desc ribed above alld treated with OTe 
by foll owing published methods (W illi:nnson and Meister. 198 1; Schmidt e{ 
nl. 1990). Drug treatment sta rteel 7 d after sensi tization with POe. Mice 
were inj ected tw ice a day ("I 2-h in te rva ls) with 10 lllg of neutralized OT 
dissolved in 100 1-'1 of distilled water. T he trca[lnent was extended fo r 8 d. 
and controls received I (JO /1-1 of distilled water. In parallel. another group ot' 
mice was scnsit·ized with ON Cll and submi tted to the same pharmacologic 
rreatlllen t. At da y 14. when tlt e last administration of OTC was given to 
mice. the an imals were challenged re.spectively with PDC Or DNCI3. and 
the contact dennatitis response was Incasurcd. 
IliSULTS 
T ime Course o f the Contact Sensitivity to Urushiols Pro. 
tocols th at lead to the inductio n of contact dermatitis to haptens 
such as d ini trofluorobenzene (Gocinski and Tigeelar , "1 990; Wal. 
dorf el (/1, 1991) arc we ll established, but there arc few reports 
describin g the conditi on s for e ffective sensitization of mice to 
llrushio ls (Dunn cI (/1, 1982). T he time co urse of th e conta ct 
dermatiti s in mi ce previously sen sitized to PO C is shown in F ig 1. 
T he response is ch aracte ri zed by car redness and swe llin g, and the 
thickn ess of the car increases lip to 72 h p ost-chall en ge. Primal) ' 
epic lltan eus exposu re of mice to uru shio ls generates all inflal11ma. 
t01·y process of ~bout 20'% of the seco ndary response. N a·ive mice 
sensitized to ONCB by epicutaneo u$ se nsiti zation on the abdomen 
show a pri ma ry infl al11m ;lto ry respon se to PDC after a challe nge. III 
con trast to g uin ea pi gs an d human be ings, mi ce show a strong 
innate response to PDC and oth e r conta c t sensitizers (data n ot 
shown). 
T he presence o f an inflamma tory respO ll se to contac t sensiti zers 
in nai ve mice ma y be explain ed by the release of tumor necrosis 
hlctor-cv ;l11d in te rl e ukin- ·I by keratinocytcs (Bass c/ ti l, 1992); these 
il1fl a l11m~tory cytoq uines m~y play an important ro le in the carl)' 
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F igure 1. Kinetics of the contact dermatitis to PDC in mice. Each 
experimenta l gro up consisted of five mice. Mice were scnsiti zed with PDC 
on th e abdo minal skin and chall enged 5 d later (-0-0-) and naive m ice 
(- \7- \7-) were cha ll en ged with POC as described in M(//""in/s nI ,d Me,/",ds. 
Mice cha lle nged with pure so lvent (-0 -0 -). T he res Ll lts arc expressed as 
111ean inCrCI11 c n ts in car thickness (rni CrOltlC[CrS ~ SEM) at variolls tiT11CS 
after exposure to POCo 
response to immunogeni c or inAammatory signa ls i'l "i"o. In 
additio n , it has been shown that keratinocytes exposed to uru shio ls 
increase the expression of adhesion m o lecules, en hancing the 
inAammatory respo nse (Barker, 1992). 
Contact Sensitivity to PDC Is Augmented in Mice Pre-
treated with Clofibrate T hi s drug is a potent peroxisomal 
proliferator in mi ce (Lazarow, 1978; Foxwo rthy l'r aI, 1990). T he 
efFectivencss of the drug treatment in indu cing peroxisome prolif-
eration was assessed by determining the activ ity of cata lase and fatty 
acid oxidase. two peroxisomal enzymes. These enzym es increased 
in activity 50'% and 570°;', over the con tro l animals, continnin g the 
efficacy of the treatm en t (da t;l not shown) . T he inAammatol'y 
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F igure 2. Clofibrate inc reases contact dernlatitis to PDC (solid 
bars) a nd DNCB (olJell bat's) . Mice sensiti zed w ith eithe r PO C o r ONCE 
were treated with clofib rate and c ha ll ellged with the respecrive aller~cn as 
described in I\/If/feria/s nlld JH tthtJds. Contro l tlnitl1a is we re SUbl111ttcd ~o the 
sa m e immunization and chall enge protocol but treated on ly w ith the drug 
vehicle. The resu lts arc ex pressed as lII ean in cre m e nts ill car thi cklless 
(micrometers ::':: SEM) at 24 h after challenge. 
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Figure 3. TDGA decreases contact dermatitis to PDC (solid 11a"s) 
and DNCB (OpCII IJa/'5). M icc sellsitized w ith e ither POC or ONCE were 
treated with TOGA and chall e llged w ith the respective all e rgen as described 
i ll 1\1ntc";als alld i\llc/hods. COll t ro l ani ma ls were SUllTllit tcd to the 5:1111C' 
inllllllniza tion and challenge protoco l but treated anI), with the drug 
vchide. T he resu lts arc cxprcs~cd as 1l1 C(1 n inCrCI11cnts ill car thickness 
(microm eters ::':: SEM) at 24 h aftcr chall e llge. 
than that of the contro l mice group trea ted w ith the veh icle (p < 
0.(1). The maximum diff'eren ce was observed between 48 and 72 h 
after chall e llge. Th is ph arm acologic efFect was specific for the PDC 
response, beca use clofibrate-pre-treated mice, se ll sitized and chal-
le llged w ith DNCI3, showed a significantly decreased respo nse (Fig 
2). 
Contact Sensitivity to PDC Is Decreased in Mice Pre-
treated with TDGA T he effect of TDGA in contact hypersen-
siti vity to PDC is shown in Fig 3. Mice sensitized w ith PO C and 
treated with TOGA, all inhibitor of the palmitoyl ca rnitinc t rans-
fe rase (Skorin N al. 1992). show a sign iticant decrease in the 
inA amm<l to ry response afte r challe nge w ith the allergen, compared 
to animals treated w ith vehicle only. At 2~ h after chall enge. treated 
mice I'eached o nly 74'% of th e response of th e con tro l group (Fig 3). 
T hi s diffe rence is statistica ll y significant (p < 0.00 1). In contrast to 
the inhibi tory efFect of TDGA on rhe response to PDC. thi s drug 
potentiates the inH am1llato ry response to ONCB up to 100% over 
the control group (Fig 3) (p < O.O()l). indi ca ting that the inhibitory 
e ffect of TDGA is specitic to r the contact dermatitis rcsponse to 
PDC. 
Contact Sensitivity to PDC Is Decreased in Mice Pre-
treated with 2-0x o-2-thiazolidine Carboxylate Figure 4 
shows the effect of OTC, a drug that increases the level of 
intracellular g lu thatione. o n tile cont;]ct dermatitis response in mice 
(W illiamson and Meister. 1981; Schmid t Cl al . 1990) T he drug 
treatm ent decreased the response to PDC in 65% (p < 0.05) w ith 
respect to the contro l gl'O up. T his effect seemed to be specific for 
the respo nse to PDC. beca use the response to DNCB in mice was 
not signiti ca ll y affected by the adm ini stratio n of OTC. 
DISCUSSION 
Con tact dermatitis due to pro-electrophili c haptens be longing to 
the fa mil y of uru shi o ls is the major cause of occupationa l dermatitis 
in widespread rural areas of the world (Benezra and Du puis. 1983; 
Benez ra. 1990) . Si nce the ea rly work of l3aer ('( at (1966). little has 
been lea rn ed abo ut the immunoc hemistry and the ill IJ i Jl(l activation 
of these lllolecuies during the cognitive and effecto r phases of the 
Rhus dermatitis. Pioneering work fi'om the group of Ka lish and 
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F igure 4. OTC decreases contact dermatitis to POC (.<o/iff //(/,-s) and 
DNCB ("I)"" II",-s). Mice se ll sit izcd c iehe r \\'itlo PJ)C or J)N CI3 were 
freaeed wielo OTC 'lIJd ch;o)J c lIgcd with Ihe respeerivc all e rgen as described 
ill l\/ ll1l'rilli s (l lId I'J l'lI l p d~. Control ;lnin \als were suhlltirtcd to dl l! sante 
il1l1I1U)li z ;l tio ll and ch:J1l cJl gc protoco l bllt trc:ltc d olll y with the drug 
ve hicle. T he rt'su lts arc expn.::sscd as H1 C'lll i ll c rClll c llts 111 ca r [hickll cs!' 
(Illicrometers :!: SEM) at 24 11 after ci,a ll eng'" 
198,) in d icarcd that m os t of the T -cell IilJ es deri ved tl-om sensitized 
indi viduilb bel o Jlged to th e C D8 I phenotype , suggesting that the 
;lctiv:ltion of urushio ls occ urs mainl y via the endoge nOll s pathway 
of anti ge n presen tatio n . T hu s, C DS I elfector T ce ll s shou ld playa 
criti cal ro le at th e effector phase of the response in hum ans. 
Fu rth e rm o re, rhe sallle authors demon stra te thar ill "il,.", uru shi o l-
self-m odifi ed peptides can be presen ted via the en dogenous path-
wa y to C DS I posit;v" T cell ~ as we ll as via the e ndocytic p<lth wn y 
to C D4 ' T ce ll clones (Ka lish ('/ Ill. 1994). 
Because it is dilll cult to ex pe rimen ta lly m ;lI1ipulate the hum;lIl 
immune sys tem ill " i"" and to m ain tai n hum an T cell ci o nes ill lI ifm 
(Mci nl l' f ai, 1')95). it ha s been diffi cul t to address key q uestions 
regardiu g cnu tact de rmatitis. T hose questions include the ro le of (i) 
LltlSaturatio n of the a liphatic chain in the all ergeni city of urtJ shi o ls; 
(ii) the mechani .ml.' ,md metabo li c pathwa ys in volved ill uru shi o l 
;Ictiva ri on; (iii) th e processing of POC-self-modified pcp tides b y 
antigen-prese nting cell s. 
To ;Iddress th ose questions we developed a murine system to test 
i ll [l il/ll the e ffect of dru gs ch;n inte rfe red w ith Eltty ac id metaboli sm 
and redox po ten tial on the immune respo nse ro PDC ill "i,/'' . 
Consiste nr w ith our hypothesis, c lotl hra te, a poten t P-450 an d 
pernxisOI ll nl in ducer in mi ce (Lazarow. 1')7R; Foxworthy, 1990), 
speciti ca l\y pot.entiated the respo nse to PD C , suggesting tha t the 
ac ti vity of the 1'-450 system andlor perox isom al activity arc 
in vo lved in PDC activatio n. Most of the sfudies desC/'ibin g the role 
of peroxisoll1es ill fatty ac id me tabolism, as we ll as th e effect of 
perox iso l1l ;oI p"olile r;orors, have bee n pe rfo rll/ed in murine hep<lto-
cytes. In add ition, the presen ce o f perox isomes in the cell line 
)-774 .3 . de ri ved t"om ;lIl tigen-presenting celb (Ralph ('I ai, 1975; 
Se in 1'1 ai, 1 ')<)3). has been recen tly described (Co uve cI al. 1992) . 
T he allthnrs dem o nstrated that th e add itioll of c is- c lofibrate to the 
culture mediull1 increased th e numhe r of peroxiso l11 es and the 
ac tivity of cata lase and Eltty acid ox idase o n the J-774.3 line, 
suppo r tin g a pos~ible ro le for perox isom es in nnti ge n-presell tin g 
cell s. T h e small ON C LI-associated decrease in inAal11mation ob-
served in clofibrate-treated mi ce Ill ay be du e to the in creased 
degradatio n of prostagl;lI1dins h y perox iso l11 es , as ha s been de-
scribed recentl y for h epatocytes (Brass ,md Kuff~ 1')91) . 
In ;Idditio n to immunogenic fa c tors, m emben of the P-450 
f~lmil y h ave bee n invo lved in all el'gic reactio lt s to several drugs 
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(Mauri-He ll weg cl ai , 1995). For sulfo namide s and aro mati c an ti" 
con vulsanrs such as ph en yto in and carbamaze pin, it has beell 
suggested that the metabo lism o f the drugs into a reactive im e nne, 
di ate by P-4S0 is a cru cial step in the ge nerati o n of imll1ul lOgcniQ 
:Idducts. T h e responder phenotype ha s been associated with a high 
level o f expression of compon ents of the P-450 system because ot· 
,I po lym o rphistII in the pro moter contro llin g th e ex press io n of th is 
cytoc hro me . T his Elc tor, in conjun cti o n w ith a slow acery la tor 
ph enotype, gene rates high level s of react ive drug in te rmed iaries 
that can m od iI')' se lf-p rotein s (Ma uri-H e ll weg ('I ai, 1<)')5) . 
T he inhibito ry effect of OTC o bserved by us is in keepin g w itl, 
the work of Schmidt ('I al ( 1990) o n the response to uru shio ls and 
suppo rt a scaven ger ro le fo r g lutathione ove r toxic ox id a ti \"(~ 
cOl1l poun ds ge nel-ated inside the cell (Reed, 1,)90); also. II high 
Icvel of g lu tathio ne m ay prevent an e ffi c ient conversio n of th l' 
catcch o l ring to the reactive qu in on e b y lowerin g th e redox 
potentia l. 
T he inhibitio n of the response to PD C after treatm ent of mi ce 
with TDGA suggests that the m etabo li sm o f lII'u shi o ls by mitochon-
dria is impo rtan t in the generati o n of ;1 reactivc inte rm ediate 
necessary to modi~y sclf.peprides. TDGA is a potent inhibi tor of 
carnitine palmitoyl transferase, a ke y enzyme involved in th e elltn 
of fat ty acids into the mi tocho ndria , and for carnitin e acyl trans~ 
ferase , a trans locase involved in the tra nsportatio ll of sho rt fatty 
ac ids to rhe mi tOcho ndria (Skorin ('/ ai, 199 2). A fi.lrth er pec ul ia'r 
t1 ndin g is tha t TOG A potentiated th e response to th l! e1ectro phil ir 
hapte n DNC13. 13ecause TDGA is an inhibitor of th e en try of Emy 
acid to th e mitoch ondria . it m ay lower the cat'lbolism of inflam-
matory m ediato rs such as prostaglandin s and le ukotrienes after 
perox isol11 ;d {3- ox idation (Sc hepers ('f ai, '1988). thu s augmen ting 
the inHal11ll1 atory response in a nonspccifi c f..1s hi ol1. 
O ur res ul ts, take n together, stro ng ly sugges t that I~ltty acid 
me tabolism is in vo lved in the ill (li{l(J acti vation of urushi o ls. T he 
s pec i~i c role of members o f the microsoma l P-45 () sys tem. ho wever, 
the pareic ipati o n of ehe peroxisoma l ,l3- ox idation in th e catabo lisnl 
o f th e a liphatic ch ain, and the in volvem ent o f th ose o rgan e ll es in 
th e intrace llular traffic and activati o n of urushi o ls by an tigcn-
prese ntillg cell s and target cell s mu st be analyzed further in cell-fret' 
system s to determine the m etabolic intermediaries responsible fo r 
the nlOdil~cation of se lf-prote ins. Pre liminary resu lts show that 
PD C is metabolized to H 2 0 , by iso lated rat hepa tocy tes, suggesting 
tha t the compound ma y be a substrate for perox isom al catabolism 
(data not shown ). 
Antigen processin g and presenta tio n of endogeno lls pcptides 
require the partic ipatio n o f proteo lyt.ic e nzymes and transpo rter-
associated proteins thac fi n a ll y deliver th e immunogeni c peptides to 
nascent M H C class I m o lec ules at the lum en of the c lldo pln slll ic 
ret icululll (Germ ain. 1 <) 1)4). It is we ll kn own chat class I an tigens arc 
ahle to present pep tides of abo ut e igh t to I fJ amino acids in length 
(Ploegh and Be naroc ll , '1993) and that transporter- associated pro-
te ins a lso contribu te to the specifi city by rransportin g peptid es of a 
similar size and specific ph ys icochemi cal properties (Germain, 
1994) . T h erefore. it is unlikely that a self-m odifi ed peptide hearing 
th e hulk), aliphati c chain fro m urtt shiols may be efFIc ien tly pro, 
cessed . tran sported. and loaded onto th e M H C class I antigen-
presenting cavicy via transporter-associated protein-depend ent pro-
cess in g. In thi s con text, th e sho rtening of rhe long aliphati c ch ain of 
urushiol s by intra ce llular meta bo li c machill ery lll ;lY in crease th~ 
e ftl cien cy of process in g and presen tation of urll shi o l- lIlOdi l'ed 
self-peptides b y reducin g th e ste ric hindrant' e of the self-\l)oditlcd 
p cptides at different lev els of the process. 
Finall y, be tter und erstandin g o Cth e pharmacog",n e ti c and itllnllt-
no logic hlctors in vo lved in Rhus derm atitis may he lp to develop 
desensitiz ing strategies and to control the o nset of the a lle rgy in a 
more specitic wa)' . Moreover, because th e basic mech anism, 
in vo lved in contact h ypersensitivities arc simil ;l r to those of several 
au to immun e and viral diseases , the eluc ida tio n oFthese mechani sms 
mi ght co ntribute to a better knowledge of the patho logic 1l1 ccil a, 
ni .1i111S of sonl c hUllU111 diseases. 
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